Oral gastric acid secretion-inhibitory activity and anti-ulcer activity of synthetic prostaglandin analogues: C-15 epimers of 15-hydroxy-15-methyl-9-oxoprostanoic acid (AY-22,469).
D000284:Administration, Oral; D000818:Animals; D003864:Depression, Chemical; D005231:Fatty Acids, Unsaturated / Q000008:administration & dosage / Q000494:pharmacology*; D005260:Female; D005750:Gastric Juice / Q000378:metabolism*; D005753:Gastric Mucosa / Q000187:drug effects*; D006863:Hydrogen-Ion Concentration; D007536:Isomerism; D008026:Ligation; D011453:Prostaglandins / Q000008:administration & dosage / Q000494:pharmacology*; D011708:Pylorus / Q000502:physiology; D051381:Rats; D012636:Secretory Rate / Q000187:drug effects; D013276:Stomach Ulcer / Q000378:metabolism; D013997:Time Factors
D005231:Fatty Acids, Unsaturated; D011453:Prostaglandins